Stock Overview
Fortis Healthcare Share Price

Fortis Healthcare Share Price

915
+7.00 (0.77%)
09 Sep, 2026 • 03:30 PM
NSE: FORTIS | Healthcare | Mid Cap
Buywith MTF at 4.74x leverage

Fortis Healthcare Annualised Returns

1 Year

-3.40%Decrease

3 Years

39.98%Increase

5 Years

26.52%Increase

10 Years

17.79%Increase

Fortis Healthcare Share Price Today


As of 9 Sep 2026, Fortis Healthcare share price is ₹915. The stock opened at ₹906.9 and had closed at ₹908 the previous day. During today’s trading session, Fortis Healthcare share price moved between ₹903.65 and ₹918.40, with an average price for the day of ₹911.02. Over the last 52 weeks, the stock has recorded a low of ₹766.80 and a high of ₹1,104.30. In terms of performance, Fortis Healthcare share price has increased by 2.5% over the past six months and has declined by 3.4% over the last year.

Fortis Healthcare Stock Performance

1W Return
0.00%
1M Return
-4.20%
6M Return
4.16%
1Y Return
-3.64%
3Y Return
169.67%
Today's High
₹918.4
Today's Low
₹903.65
52-Week High
₹1104.3
52-Week Low
₹766.8
Prev. Close
₹908.00
Open
₹906.90
Face Value
₹10
Mkt Cap (Cr.)
₹68,550
PE Ratio
305.00

Fortis Healthcare Futures & Options

Fortis Healthcare Share Price Chart

Fortis Healthcare Company background

Founded in: 1996
Managing director: Ashutosh Raghuvanshi

Fortis Healthcare Limited was incorporated on February 28, 1996, by the Singh brothers as an extension of their pharmaceutical legacy. The company is headquartered at the Fortis Memorial Research Institute in Gurgaon, with its registered office in Mohali, Punjab. It operates 36 healthcare facilities across India, Dubai, and Sri Lanka, offering a range of medical services. Fortis is listed on both the Bombay Stock Exchange (BSE: 532843) and the National Stock Exchange (NSE: FORTISEQ), and is backed by Malaysia’s IHH Healthcare.

Fortis Healthcare operates through three primary segments: hospitals, diagnostics, and pharmacies. The hospital division provides multi-specialty tertiary and quaternary care services including cardiology, oncology, orthopaedics, neurology, and more. The diagnostics arm, Agilus Diagnostics, offers pathology and imaging services through a broad network. Its pharmacy business supports the hospital ecosystem and generates additional retail revenue. The company earns primarily through inpatient and outpatient services, diagnostics, pharmacy sales, and day-care procedures. Medical tourism contributes to the revenue as international patients seek cost-effective, high-quality treatment across Fortis facilities.

  • 1996: Incorporated and launched its first hospital in Mohali, Punjab
  • 2005: Acquired Escorts Heart and Research Centre in Delhi
  • 2007: Launched its IPO and got listed on BSE and NSE
  • 2015: Fortis Hospital Noida won the National Energy Conservation Award
  • 2015: Received the Golden Globe Tigers Award for patient safety initiatives
  • 2018: Founders resigned amid financial issues; IHH Healthcare acquired a 31.1% stake
  • 2019: Acquired RHT Health Trust assets worth approximately ₹4,650 crore
  • 2023: Completed acquisition of Medeor Hospital in Manesar
  • 2024: Announced acquisition of a 31% stake in Agilus Diagnostics
  • 2025: Won seven International Medical Value Travel Awards for excellence in various specialties
  • Tracks energy and water usage across hospitals with 19 active efficiency initiatives
  • Focuses on eco-friendly biomedical waste management and carbon footprint reduction
  • Implements WHO surgical safety protocols to enhance patient care
  • Each unit has designated ESG champions driving sustainable practices
  • Long-term goal includes embedding sustainability into core operations by 2030
  • Won the Golden Globe Tigers Award for excellence in patient safety practices
  • Received the National Energy Conservation Award for energy efficiency at the Noida hospital
  • Honoured at the International Patient Safety Conference for innovation and leadership
  • Secured seven awards at the Medical Value Travel Summit across key specialties like cardiology, oncology, and orthopaedics

Fortis Healthcare Financial Highlights


For the full year FY2026–2027, revenue reached ₹9178.5 crore and profit touched at ₹1047.84 crore. As of Jun '26, Fortis Healthcare’s market capitalisation stood at ₹68,550.20 crores. Shareholding as of Jun '26 shows promoters holding 31.2%, with FIIs at 25.2%, DIIs at 32.2%, and public at 11.4%.
Fortis Healthcare SIP Returns Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 6,27,125 in 5 years with a gain of 3,27,125 (+109.04%)
Fortis Healthcare Fundamental

Market Cap (in crs)

68,550.20

Face Value

10

Turnover (in lacs)

6,136.50

Key Metrics

Qtr Change %
-7.5
Dividend yield 1yr %
Low in industry
0.1

Fortis Healthcare Key Financials

View more
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Loading chart...
Fortis Healthcare Result Highlights
  • Fortis Healthcare reported a 2.6% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 15.6%.

  • Its expenses for the quarter were up by 0.6% QoQ and 11.9% YoY.

  • The net profit increased 31.7% QoQ and increased 89.5% YoY.

  • The earnings per share (EPS) of Fortis Healthcare stood at 3.3 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Fortis Healthcare Technical Analysis

Moving Averages Analysis
915
Current Price
Bullish Moving Averages
6
Bearish Moving Averages
10
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
5 EMA
910.40
10 EMA
912.60
12 EMA
913.50
20 EMA
917.50
26 EMA
920.60
50 EMA
929.20
100 EMA
930.30
200 EMA
912.70

Delivery & Volume

Loading chart...

Day

74.70%

Week

68.10%

Month

61.80%

907.78
Pivot
Resistance
First Resistance
913.22
Second Resistance
918.43
Third Resistance
923.87
Support
First Support
902.57
Second support
897.13
Third Support
891.92
Relative Strength Index
44.23
Money Flow Index
51.74
MACD
-7.15
MACD Signal
-7.69
Average True Range
19.53
Average Directional Index
7.55
Rate of Change (21)
-3.93
Rate of Change (125)
1.73
Compare

Fortis Healthcare Shareholding Pattern

Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Promoter
31.2%
Foreign Institutions
25.2%
Mutual Funds
25.8%
Domestic Institutions
32.2%
Public
11.4%
Fortis Healthcare Latest News
04 SEP 2026
01 SEP 2026
01 SEP 2026

Fortis Healthcare share price is ₹915 in NSE and ₹911.9 in BSE as on 9/9/2026.

Fortis Healthcare share price in the past 1-year return was -3.64. The Fortis Healthcare share hit a 1-year low of Rs. 766.8 and a 1-year high of Rs. 1104.3.

The market cap of Fortis Healthcare is Rs. 68550.2 Cr. as of 9/9/2026.

The PE ratios of Fortis Healthcare is 305 as of 9/9/2026.

The PB ratios of Fortis Healthcare is 7.48 as of 9/9/2026

The Mutual Fund Shareholding in Fortis Healthcare was 25.81% at the end of 9/9/2026.

You can easily buy Fortis Healthcare shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Fortis Healthcare share price is ₹1104.3 and ₹766.8 as of 9/9/2026.

Please be aware that Fortis Healthcare stock prices are subject to continuous fluctuations due to various factors.